Martin Jefson PhD

Dr. Martin R. Jefson, also known as Marty, Ph.D., is a Co-Founder of Rodin Therapeutics Inc. and serves as its Chief Scientific Officer. Dr. Jefson serves as a Venture Partner and Executive-in-Residence at Atlas Venture L.P. He is a Co-Founder Ataxion, Inc. serves as its Chief Scientific Officer. Prior to joining Atlas, he spent 27 years at Pfizer, most recently serving as head of neuroscience research. More than 30 development candidates were discovered during his tenure, including Chantix. Dr. Jefson serves as a Member of Scientific Advisory Board at Mnemosyne Pharmaceuticals, Inc.